Eosinophils, ribonucleases and host defense: solving the puzzle

Area of Science:

• Immunology
• Virology
• Evolutionary Biology

Background:

• Eosinophils are key immune cells, but their role in host defense is not fully understood.
• Eosinophil-derived neurotoxin (EDN/RNase 2) and eosinophil cationic protein (ECP/RNase 3) are major eosinophil effector proteins.
• Evolutionary studies reveal significant diversification in primate and rodent EDNs and ECPs, suggesting a specific function.

Purpose of the Study:

• To investigate the potential antiviral role of eosinophil ribonucleases against respiratory syncytial virus (RSV).
• To explore the association between eosinophils, their ribonucleases, and viral diseases.
• To determine if EDN and ECP contribute to innate and specific antiviral defense mechanisms.

Main Methods:

• Evolutionary analysis of EDN and ECP sequences in primates and rodents.
• In vitro experiments assessing the effect of eosinophils and EDN on RSV infectivity.
• Evaluation of EDN's independent antiviral capabilities.

Main Results:

• Eosinophils demonstrate a direct, ribonuclease-dependent reduction in RSV infectivity in vitro.
• Eosinophil-derived neurotoxin (EDN) exhibits independent antiviral activity against RSV.
• Evolutionary data suggests EDN/ECP ribonucleases are evolving for a specific, ribonuclease-related function.

Conclusions:

• Eosinophil ribonucleases, EDN and ECP, possess significant antiviral properties.
• These ribonucleases may constitute a previously unrecognized component of the host's antiviral defense.
• Further research is warranted to elucidate the full scope of eosinophil involvement in antiviral immunity.